$MRK Headlines Merck, J.P. Morgan lead Dow decli
Post# of 89346
Posted On: 11/17/2013 6:49:40 PM
$MRK Headlines
Merck, J.P. Morgan lead Dow decliners 9:35 a.m. Nov. 13, 2013 - Laura Mandaro
Merck, Cisco lead gainers in Dow industrials 4:03 p.m. Nov. 12, 2013 - Polya Lesova
Planned layoffs up 13.5% in October: Challenger 7:30 a.m. Nov. 6, 2013 - Steve Goldstein
Newscast: S&P 500 notches year's 32nd record high 8:08 p.m. Oct. 28, 2013 - MarketWatch
J.C. Penney, Bristol-Myers top S&P 500 7:08 p.m. Oct. 28, 2013 - Saumya Vaishampayan
S&P up for 8th day in 9; Dow, Nasdaq flat 4:57 p.m. Oct. 28, 2013 - Victor Reklaitis
Newscast: Stocks mixed after lackluster day 4:26 p.m. Oct. 28, 2013 - MarketWatch
Newscast: Car reliability ranks get new members 2:28 p.m. Oct. 28, 2013 - MarketWatch
Merck shares stumble on earnings weakness, talk of divesting assets 10:58 a.m. Oct. 28, 2013 - blogs.marketwatch.com
Merck, down 2.2%, leads Dow average lower 9:34 a.m. Oct. 28, 2013 - Laura Mandaro
Stock futures continue to waver after data 9:30 a.m. Oct. 28, 2013 - Sara Sjolin
Apple is Monday’s stock to watch as results loom 8:21 a.m. Oct. 28, 2013 - Sue Chang
Merck profit down 35% as Singulair sales fall 7:25 a.m. Oct. 28, 2013 - MarketWatch.com
Merck third-quarter profit, revenue fall 7:17 a.m. Oct. 28, 2013 - Saumya Vaishampayan
Merck narrows 2013 EPS guidance; holds sales view 7:10 a.m. Oct. 28, 2013 - Saumya Vaishampayan
Merck Q3 adj. EPS edges down to $0.92 vs. $0.95 7:03 a.m. Oct. 28, 2013 - Saumya Vaishampayan
Merck Q3 sales down to $11.03 bln vs. $11.49 bln 7:03 a.m. Oct. 28, 2013 - Saumya Vaishampayan
Merck Q3 profit falls to $1.12 bln vs. $1.73 bln 7:03 a.m. Oct. 28, 2013 - Saumya Vaishampayan
Merck Q3 EPS falls to $0.38 from $0.56 year ago 7:03 a.m. Oct. 28, 2013 - Saumya Vaishampayan
Small caps surge, the year's best trading day and R.I.P. Lou Reed 6:37 a.m. Oct. 28, 2013 - blogs.marketwatch.com
Paul Tudor Jones - High Impact Sells 1:12 p.m. Nov. 16, 2013 - GuruFocus.com
Chevron’s Mississippi Refinery Fire Kills One Employee and 2 Other Dow Movers to Watch 2:08 p.m. Nov. 15, 2013 - Wall St. Cheat Sheet
Akorn Acquires Eye Drugs From Merck; Stock Hits High 11:14 a.m. Nov. 15, 2013 - Investors Business Daily
3 Turkeys to Sell Before Thanksgiving 2:00 a.m. Nov. 15, 2013 - InvestorPlace.com
German Merck Hikes Its 2013 Profit Projection and 2 Other Dow Movers to Watch 1:11 p.m. Nov. 14, 2013 - Wall St. Cheat Sheet
Chevron Judgment Cut in Half But Upheld in Ecuador and 2 Other Dow Movers to Watch 1:41 p.m. Nov. 13, 2013 - Wall St. Cheat Sheet
What You Need to Know About New Heart-Care Guidelines 10:17 a.m. Nov. 13, 2013 - WSJ.com
Dow Today: McDonald's Corporation (MCD) Leads The Day Higher, Merck (MRK) Lags 10:00 a.m. Nov. 13, 2013 - TheStreet.com
Merck May Lose Out From New Treatment Guide For Cholesterol 9:36 a.m. Nov. 13, 2013 - Seeking Alpha
UBS Top Stocks to Buy for 2014: GE, GM, Citigroup and Six More 7:48 a.m. Nov. 13, 2013 - 247WallSt.com
New Guidelines: Doctors to Push Use of Cholesterol Drugs 4:00 a.m. Nov. 13, 2013 - InvestorPlace.com
Merck Enters into Further Global Co-Development and Commercialization Agreement for PARP Inhibitor with Chinese R&D Company BeiGene 2:30 a.m. Nov. 13, 2013 - CNW Group
5 Overpriced Stocks to Ditch Now 12:15 a.m. Nov. 13, 2013 - InvestorPlace.com
A single U.S. birth delivery costs $21,000, triplets $400,000 8:07 p.m. Nov. 12, 2013 - United Press International
Dow Today: Merck (MRK) Leads The Day Higher, Chevron (CVX) Lags 4:30 p.m. Nov. 12, 2013 - TheStreet.com
Combination Therapies Hold Key To Future Cancer Treatments 2:32 p.m. Nov. 12, 2013 - Seeking Alpha
Merck (MRK) Highlighted As Momo Momentum Stock 10:43 a.m. Nov. 12, 2013 - TheStreet.com
Stock Market News for November 12, 2013 - Market News 10:06 a.m. Nov. 12, 2013 - Zacks.com
Merck Becomes #22 Most Shorted Dow Stock, Replacing Coca-Cola 9:18 a.m. Nov. 12, 2013 - TheStreet.com
Short Sellers Made Big Changes in High-Yield Dividend Stocks 8:28 a.m. Nov. 12, 2013 - 247WallSt.com
Interim Data to Be Presented for MK-3475, Merck's Investigational Anti-PD-1 Immunotherapy, in Patients with Advanced Melanoma 5:00 p.m. Nov. 15, 2013 - BusinessWire
Akorn Acquires Three Branded Ophthalmic Products from Merck 9:00 a.m. Nov. 15, 2013 - BusinessWire
Merck Strengthens its Presence in China with New Pharmaceutical Manufacturing Facility 2:00 a.m. Nov. 15, 2013 - PR Newswire
Today's Research: Pfizer Inc., Merck & Co. Inc., AbbVie Inc., and Zogenix Inc. 6:21 p.m. Nov. 14, 2013 - PR Newswire
Healthcare Sector Announces Financial Results and Financial Restatements - Research Report on Merck, Health Management Associates, ZELTIQ, MAKO, and Amarin 8:00 a.m. Nov. 13, 2013 - PR Newswire
Merck Enters into Further Global Co-Development and Commercialization Agreement for PARP Inhibitor with Chinese R&D Company BeiGene 2:30 a.m. Nov. 13, 2013 - PR Newswire
InSite Vision Reports Third Quarter 2013 Financial Results 4:03 p.m. Nov. 12, 2013 - BusinessWire
Merck Animal Health HomeAgain® Announces Hero of the Year Award Winner 8:00 a.m. Nov. 12, 2013 - PR Newswire
Acquisition, Corporate News Analysis: Apple Inc, Bank of America, Intel Corporation, Merck & Co, Globalstar 9:15 a.m. Nov. 11, 2013 - PR Newswire
Clinical Study Results, Approvals, Financial Results, New Facilities, and Business Expansions - Research Report on Merck, UnitedHealth Group, NPS Pharmaceuticals, Abbott, and Medtronic 8:00 a.m. Nov. 11, 2013 - PR Newswire
ALK's partner in North America, Merck, reports Phase III data on investigational grass sublingual allergy immunotherapy tablet 12:48 p.m. Nov. 9, 2013 - GlobeNewswire
Merck's Investigational Grass Sublingual Allergy Immunotherapy Tablet Significantly Reduced Allergy Symptoms and Need for Symptom-Relief Medication in Adults and Children in Pivotal Phase III Study 12:00 p.m. Nov. 9, 2013 - BusinessWire
Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Cuida tu Diabetes, Cuida tu Corazon to Cook up Delicious, Diabetes-Friendly Dishes for Hispanics with Type 2 Diabetes 12:00 p.m. Nov. 8, 2013 - PR Newswire
EMD Serono Announces Appointment of Paris Panayiotopoulos as President and Managing Director 9:00 a.m. Nov. 8, 2013 - BusinessWire
Positive Clinical Data, Upcoming Presentations, and Completed Acquisitions - Research Report on Merck, Perrigo, Celgene, Cigna, and Boston Scientific 8:00 a.m. Nov. 6, 2013 - PR Newswire
Merck Animal Health Launches Global Awareness Campaign to Support Pet Diabetes Month(TM) 6:42 p.m. Nov. 5, 2013 - PR Newswire
Regado Biosciences, Inc. Appoints World-Renowned Leader in Cardiovascular Research and Former Global Head of Cardiovascular Diseases for Merck & Co., to Board of Directors 5:01 p.m. Nov. 5, 2013 - PR Newswire
InSite Vision Announces Appeal by Sandoz Inc. of Court Judgment Upholding All AzaSite(R) Patents in Patent Infringement Lawsuit 4:36 p.m. Nov. 5, 2013 - BusinessWire
Codexis Appoints Greg Hughes, Ph.D., as Vice President, Strategic Alliance & Product Development 4:01 p.m. Nov. 5, 2013 - BusinessWire
Surprising Earnings and News Updates: General Motors, BlackBerry, American International Group, First Solar, Merck & Co. 1:55 p.m. Nov. 4, 2013 - PR Newswire
Merck, J.P. Morgan lead Dow decliners 9:35 a.m. Nov. 13, 2013 - Laura Mandaro
Merck, Cisco lead gainers in Dow industrials 4:03 p.m. Nov. 12, 2013 - Polya Lesova
Planned layoffs up 13.5% in October: Challenger 7:30 a.m. Nov. 6, 2013 - Steve Goldstein
Newscast: S&P 500 notches year's 32nd record high 8:08 p.m. Oct. 28, 2013 - MarketWatch
J.C. Penney, Bristol-Myers top S&P 500 7:08 p.m. Oct. 28, 2013 - Saumya Vaishampayan
S&P up for 8th day in 9; Dow, Nasdaq flat 4:57 p.m. Oct. 28, 2013 - Victor Reklaitis
Newscast: Stocks mixed after lackluster day 4:26 p.m. Oct. 28, 2013 - MarketWatch
Newscast: Car reliability ranks get new members 2:28 p.m. Oct. 28, 2013 - MarketWatch
Merck shares stumble on earnings weakness, talk of divesting assets 10:58 a.m. Oct. 28, 2013 - blogs.marketwatch.com
Merck, down 2.2%, leads Dow average lower 9:34 a.m. Oct. 28, 2013 - Laura Mandaro
Stock futures continue to waver after data 9:30 a.m. Oct. 28, 2013 - Sara Sjolin
Apple is Monday’s stock to watch as results loom 8:21 a.m. Oct. 28, 2013 - Sue Chang
Merck profit down 35% as Singulair sales fall 7:25 a.m. Oct. 28, 2013 - MarketWatch.com
Merck third-quarter profit, revenue fall 7:17 a.m. Oct. 28, 2013 - Saumya Vaishampayan
Merck narrows 2013 EPS guidance; holds sales view 7:10 a.m. Oct. 28, 2013 - Saumya Vaishampayan
Merck Q3 adj. EPS edges down to $0.92 vs. $0.95 7:03 a.m. Oct. 28, 2013 - Saumya Vaishampayan
Merck Q3 sales down to $11.03 bln vs. $11.49 bln 7:03 a.m. Oct. 28, 2013 - Saumya Vaishampayan
Merck Q3 profit falls to $1.12 bln vs. $1.73 bln 7:03 a.m. Oct. 28, 2013 - Saumya Vaishampayan
Merck Q3 EPS falls to $0.38 from $0.56 year ago 7:03 a.m. Oct. 28, 2013 - Saumya Vaishampayan
Small caps surge, the year's best trading day and R.I.P. Lou Reed 6:37 a.m. Oct. 28, 2013 - blogs.marketwatch.com
Paul Tudor Jones - High Impact Sells 1:12 p.m. Nov. 16, 2013 - GuruFocus.com
Chevron’s Mississippi Refinery Fire Kills One Employee and 2 Other Dow Movers to Watch 2:08 p.m. Nov. 15, 2013 - Wall St. Cheat Sheet
Akorn Acquires Eye Drugs From Merck; Stock Hits High 11:14 a.m. Nov. 15, 2013 - Investors Business Daily
3 Turkeys to Sell Before Thanksgiving 2:00 a.m. Nov. 15, 2013 - InvestorPlace.com
German Merck Hikes Its 2013 Profit Projection and 2 Other Dow Movers to Watch 1:11 p.m. Nov. 14, 2013 - Wall St. Cheat Sheet
Chevron Judgment Cut in Half But Upheld in Ecuador and 2 Other Dow Movers to Watch 1:41 p.m. Nov. 13, 2013 - Wall St. Cheat Sheet
What You Need to Know About New Heart-Care Guidelines 10:17 a.m. Nov. 13, 2013 - WSJ.com
Dow Today: McDonald's Corporation (MCD) Leads The Day Higher, Merck (MRK) Lags 10:00 a.m. Nov. 13, 2013 - TheStreet.com
Merck May Lose Out From New Treatment Guide For Cholesterol 9:36 a.m. Nov. 13, 2013 - Seeking Alpha
UBS Top Stocks to Buy for 2014: GE, GM, Citigroup and Six More 7:48 a.m. Nov. 13, 2013 - 247WallSt.com
New Guidelines: Doctors to Push Use of Cholesterol Drugs 4:00 a.m. Nov. 13, 2013 - InvestorPlace.com
Merck Enters into Further Global Co-Development and Commercialization Agreement for PARP Inhibitor with Chinese R&D Company BeiGene 2:30 a.m. Nov. 13, 2013 - CNW Group
5 Overpriced Stocks to Ditch Now 12:15 a.m. Nov. 13, 2013 - InvestorPlace.com
A single U.S. birth delivery costs $21,000, triplets $400,000 8:07 p.m. Nov. 12, 2013 - United Press International
Dow Today: Merck (MRK) Leads The Day Higher, Chevron (CVX) Lags 4:30 p.m. Nov. 12, 2013 - TheStreet.com
Combination Therapies Hold Key To Future Cancer Treatments 2:32 p.m. Nov. 12, 2013 - Seeking Alpha
Merck (MRK) Highlighted As Momo Momentum Stock 10:43 a.m. Nov. 12, 2013 - TheStreet.com
Stock Market News for November 12, 2013 - Market News 10:06 a.m. Nov. 12, 2013 - Zacks.com
Merck Becomes #22 Most Shorted Dow Stock, Replacing Coca-Cola 9:18 a.m. Nov. 12, 2013 - TheStreet.com
Short Sellers Made Big Changes in High-Yield Dividend Stocks 8:28 a.m. Nov. 12, 2013 - 247WallSt.com
Interim Data to Be Presented for MK-3475, Merck's Investigational Anti-PD-1 Immunotherapy, in Patients with Advanced Melanoma 5:00 p.m. Nov. 15, 2013 - BusinessWire
Akorn Acquires Three Branded Ophthalmic Products from Merck 9:00 a.m. Nov. 15, 2013 - BusinessWire
Merck Strengthens its Presence in China with New Pharmaceutical Manufacturing Facility 2:00 a.m. Nov. 15, 2013 - PR Newswire
Today's Research: Pfizer Inc., Merck & Co. Inc., AbbVie Inc., and Zogenix Inc. 6:21 p.m. Nov. 14, 2013 - PR Newswire
Healthcare Sector Announces Financial Results and Financial Restatements - Research Report on Merck, Health Management Associates, ZELTIQ, MAKO, and Amarin 8:00 a.m. Nov. 13, 2013 - PR Newswire
Merck Enters into Further Global Co-Development and Commercialization Agreement for PARP Inhibitor with Chinese R&D Company BeiGene 2:30 a.m. Nov. 13, 2013 - PR Newswire
InSite Vision Reports Third Quarter 2013 Financial Results 4:03 p.m. Nov. 12, 2013 - BusinessWire
Merck Animal Health HomeAgain® Announces Hero of the Year Award Winner 8:00 a.m. Nov. 12, 2013 - PR Newswire
Acquisition, Corporate News Analysis: Apple Inc, Bank of America, Intel Corporation, Merck & Co, Globalstar 9:15 a.m. Nov. 11, 2013 - PR Newswire
Clinical Study Results, Approvals, Financial Results, New Facilities, and Business Expansions - Research Report on Merck, UnitedHealth Group, NPS Pharmaceuticals, Abbott, and Medtronic 8:00 a.m. Nov. 11, 2013 - PR Newswire
ALK's partner in North America, Merck, reports Phase III data on investigational grass sublingual allergy immunotherapy tablet 12:48 p.m. Nov. 9, 2013 - GlobeNewswire
Merck's Investigational Grass Sublingual Allergy Immunotherapy Tablet Significantly Reduced Allergy Symptoms and Need for Symptom-Relief Medication in Adults and Children in Pivotal Phase III Study 12:00 p.m. Nov. 9, 2013 - BusinessWire
Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Cuida tu Diabetes, Cuida tu Corazon to Cook up Delicious, Diabetes-Friendly Dishes for Hispanics with Type 2 Diabetes 12:00 p.m. Nov. 8, 2013 - PR Newswire
EMD Serono Announces Appointment of Paris Panayiotopoulos as President and Managing Director 9:00 a.m. Nov. 8, 2013 - BusinessWire
Positive Clinical Data, Upcoming Presentations, and Completed Acquisitions - Research Report on Merck, Perrigo, Celgene, Cigna, and Boston Scientific 8:00 a.m. Nov. 6, 2013 - PR Newswire
Merck Animal Health Launches Global Awareness Campaign to Support Pet Diabetes Month(TM) 6:42 p.m. Nov. 5, 2013 - PR Newswire
Regado Biosciences, Inc. Appoints World-Renowned Leader in Cardiovascular Research and Former Global Head of Cardiovascular Diseases for Merck & Co., to Board of Directors 5:01 p.m. Nov. 5, 2013 - PR Newswire
InSite Vision Announces Appeal by Sandoz Inc. of Court Judgment Upholding All AzaSite(R) Patents in Patent Infringement Lawsuit 4:36 p.m. Nov. 5, 2013 - BusinessWire
Codexis Appoints Greg Hughes, Ph.D., as Vice President, Strategic Alliance & Product Development 4:01 p.m. Nov. 5, 2013 - BusinessWire
Surprising Earnings and News Updates: General Motors, BlackBerry, American International Group, First Solar, Merck & Co. 1:55 p.m. Nov. 4, 2013 - PR Newswire
(0)
(0)